MAPK8 and cancer: In cancer cells, PCA downregulates cyclin D1 to inhibit proliferation, blocking G1-to-S phase transition and elevating p53 to induce apoptosis, effects linked to c-Jun N-terminal kinase (JNK) and p38 activation [90].